Back to Trades
Spyre Therapeutics, Inc.
SYRECIK: 0001636282
Follow SYRE
Track Spyre Therapeutics, Inc. insider trades on your dashboard. Email alerts with a subscription.
Spyre Therapeutics, Inc. (SYRE) has recorded 30 insider filings from 10 unique insiders, totaling $460.9M in trading activity (net selling). Insiders have sold $422.4M while purchasing $0. Insider sales can reflect personal financial planning rather than a bearish view — always consider the full context. The most active insider by volume is Fairmount Funds Management LLC. All data sourced from SEC Form 4 filings and updated as new disclosures are filed.
Total Volume
$460.9M
Purchases
$0
Sales
$422.4M
Unique Insiders
10
Recent Insider Trades
30 loaded
| Jun 23 | SYRE Spyre Therapeutics, Inc. | Fairmount Funds Management LLC | Director | Sell | $399.7M |
| Jun 23 | SYRE Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Director | Sell | $2.0M |
| Jun 3 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon | Chief Medical Officer | Sell | $625.0K |
| Jun 3 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sell | $532.9K |
| Jun 3 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $1.1M |
| May 29 | SYRE Spyre Therapeutics, Inc. | Milligan Sandra | Director | Other | $0 |
| May 29 | SYRE Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Director | Other | $0 |
| May 29 | SYRE Spyre Therapeutics, Inc. | McKenna Mark C. | Director | Other | $0 |
| May 29 | SYRE Spyre Therapeutics, Inc. | Stelzer Laurie | Director | Other | $0 |
| May 29 | SYRE Spyre Therapeutics, Inc. | Albers Jeffrey W. | Director | Other | $0 |
| May 29 | SYRE Spyre Therapeutics, Inc. | Fairmount Funds Management LLC | Director | Other | $0 |
| May 8 | SYRE Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Director | Sell | $6.0M |
| May 1 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $1.1M |
| May 1 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sell | $892.1K |
| May 1 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon | Chief Medical Officer | Sell | $5.6M |
| Apr 3 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $739.9K |
| Apr 3 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon | Chief Medical Officer | Sell | $397.9K |
| Apr 3 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sell | $370.1K |
| Mar 3 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sell | $101.6K |
| Mar 3 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $632.9K |
| Feb 4 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $492.0K |
| Jan 23 | SYRE Spyre Therapeutics, Inc. | HENDERSON MICHAEL THOMAS | Director | Other | $0 |
| Jan 13 | SYRE Spyre Therapeutics, Inc. | Sloan Sheldon | Chief Medical Officer | Other | $0 |
| Jan 13 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Other | $0 |
| Jan 13 | SYRE Spyre Therapeutics, Inc. | King-Jones Heidy | See Remarks | Other | $0 |
| Jan 13 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Other | $0 |
| Jan 6 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $460.1K |
| Dec 3 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $435.4K |
| Nov 5 | SYRE Spyre Therapeutics, Inc. | Turtle Cameron | Chief Executive Officer, Director | Sell | $1.0M |
| Sep 3 | SYRE Spyre Therapeutics, Inc. | Burrows Scott L | Chief Financial Officer | Sell | $299.6K |
30 filings